RR's Pivot to RaaS: Evading Short-Term Setback for Long-Term Growth — Neutral
RR Zacks Investment Research — November 18, 2025Richtech Robotics shifts to a RaaS model, trading short-term revenue softness for recurring MSAs and strong margins as its long-term growth strategy takes shape.
Surprisingly Secure Pricing: Zscaler Q4 FY25 Earnings Review — Positive
ZS Seeking Alpha — November 18, 2025Zscaler is rated Buy, with a suggested stop at $258, offering a 2:1 to 3.3:1 risk/reward from current levels. ZS fundamentals remain strong: 21% YoY revenue growth, stable margins, and nearly $2bn net cash, justifying its premium valuation. Despite high valuation multiples, ZS is outperforming software peers, reflecting confidence in cybersecurity demand amid AI and datacenter growth.
DXCM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that DexCom, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit — Neutral
DXCM GlobeNewsWire — November 18, 2025NEW YORK, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against DexCom, Inc. (“DexCom” or “the Company”) (NASDAQ: DXCM) and certain of its officers.
KMX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that CarMax, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit — Neutral
KMX GlobeNewsWire — November 18, 2025NEW YORK, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against CarMax, Inc. (“CarMax” or “the Company”) (NYSE: KMX) and certain of its officers.
California Resources Corporation Achieves MiQ ‘Grade A' Certification for its Ventura Basin Assets — Neutral
CRC GlobeNewsWire — November 18, 2025VENTURA, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- California Resources Corporation (NYSE: CRC) received a ‘Grade A' certification through MiQ's Methane Emissions Performance Standard for its production segment operating assets in Ventura County.
Deadline Alert: RCI Hospitality Holdings, Inc. (RICK) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit — Neutral
RICK GlobeNewsWire — November 18, 2025LOS ANGELES, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming November 20, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired RCI Hospitality Holdings, Inc. (“RCI” or the “Company”) (NASDAQ: RICK) securities between December 15, 2021 and September 16, 2025, inclusive (the “Class Period”).
Deadline Alert: Fortinet, Inc. (FTNT) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit — Neutral
FTNT GlobeNewsWire — November 18, 2025LOS ANGELES, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming November 21, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Fortinet, Inc. (“Fortinet” or the “Company”) (NASDAQ: FTNT) common stock between November 8, 2024 and August 6, 2025, inclusive (the “Class Period”).
Deadline Alert: James Hardie Industries plc (JHX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit — Neutral
JHX GlobeNewsWire — November 18, 2025LOS ANGELES, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming December 23, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired James Hardie Industries plc (“James Hardie” or the “Company”) (NYSE: JHX) common stock (previously American Depositary Shares until the Company's conversion to common stock on July 1, 2025) between May 20, 2025 and August 18, 2025, inclusive (the “Class Period”).
Synopsys, Inc. (SNPS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit — Neutral
SNPS PRNewsWire — November 18, 2025LOS ANGELES, Nov. 18, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Synopsys, Inc. ("Synopsys" or the "Company") (NASDAQ: SNPS).
Law Offices of Howard G. Smith Encourages Freeport-McMoran Inc. (FCX) Shareholders To Inquire About Securities Fraud Class Action — Neutral
FCX Business Wire — November 18, 2025BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Freeport-McMoran Inc. (“Freeport” or the “Company”) (NYSE: FCX) securities between February 15, 2022 and September 24, 2025, inclusive (the “Class Period”). Freeport investors have until January 12, 2026 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN FREEPORT-MCMORAN INC. (FCX), CONTACT THE LAW OFFICES OF HOWARD.
Zenity Announces Inline Prevention for Microsoft Foundry and General Availability for Capabilities in Microsoft Copilot Studio — Neutral
MSFT Business Wire — November 18, 2025NEW YORK--(BUSINESS WIRE)-- #AIAgentSecuritySummit--Zenity, a leading end-to-end security and governance platform for AI agents, today announced an inline prevention solution for Microsoft Foundry, created to meet enterprise security and compliance needs. This launch also marks the general availability of Zenity's inline prevention capabilities for Microsoft Copilot Studio, enabling organizations to implement real-time controls on agents built, deployed and operated across the Microsoft agentic stack. Microsoft Foundry.
Deadline Alert: Telix Pharmaceuticals Limited (TLX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit — Neutral
TLX Business Wire — November 18, 2025LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP reminds investors of the upcoming January 9, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Telix Pharmaceuticals Limited (“Telix” or the “Company”) (NASDAQ: TLX) securities between February 21, 2025 and August 28, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR TELIX INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING C.
Avantor, Inc. (AVTR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit — Neutral
AVTR PRNewsWire — November 18, 2025LOS ANGELES , Nov. 18, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Avantor, Inc. ("Avantor" or the "Company") (NYSE: AVTR) have opportunity to lead the securities fraud class action lawsuit.
MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit — Neutral
MLTX PRNewsWire — November 18, 2025BENSALEM, Pa., Nov. 18, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against MoonLake Immunotherapeutics ("MoonLake" or the "Company") (NASDAQ: MLTX).
Deadline Alert: Stride, Inc. (LRN) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit — Neutral
LRN Business Wire — November 18, 2025LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP reminds investors of the upcoming January 12, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Stride, Inc. (“Stride” or the “Company”) (NYSE: LRN) securities between October 22, 2024 and October 28, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR STRIDE INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER.
Lifordi Immunotherapeutics Secures Strategic Investment from Sanofi Ventures and Additional Capital from Existing Investors — Neutral
SNY Business Wire — November 18, 2025BURLINGTON, Mass.--(BUSINESS WIRE)-- #ADCs--Lifordi Immunotherapeutics, Inc., a clinical-stage biotech company developing antibody-drug conjugates (ADCs) for the treatment of autoimmune and inflammatory disorders, today announced a strategic investment from Sanofi Ventures, the venture arm of global healthcare leader Sanofi, and funding from existing investors ARCH Ventures, 5AM Ventures, and Atlas Venture. The new funds bring the total raised to $112 million and support an ongoing Phase 1 study in Rhe.
Baxter International, Inc. (BAX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit — Neutral
BAX PRNewsWire — November 18, 2025LOS ANGELES , Nov. 18, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Baxter International, Inc. ("Baxter" or the "Company") (NYSE: BAX) have opportunity to lead the securities fraud class action lawsuit.
SKYE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Skye Bioscience, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit — Neutral
SKYE GlobeNewsWire — November 18, 2025NEW YORK, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Skye Bioscience, Inc. (“Skye” or “the Company”) (NASDAQ: SKYE) and certain of its officers.
KBR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that KBR, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit — Neutral
KBR GlobeNewsWire — November 18, 2025NEW YORK, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against KBR, Inc. (“KBR” or “the Company”) (NYSE: KBR) and certain of its officers.
DraftKings CEO and Co-Founder Jason Robins Named the 2025 American Gambling Awards C-Suite Executive of the Year — Neutral
DKNG GAMB Business Wire — November 18, 2025CHARLOTTE, N.C.--(BUSINESS WIRE)--The American Gambling Awards is pleased to announce that Jason Robins, Chief Executive Officer and Co-Founder of DraftKings Inc. (Nasdaq: DKNG) (“DraftKings”), has been named C-Suite Executive of the Year for 2025. His vision has fueled DraftKings' growth while steering the broader industry toward a more interactive, sustainable, and fan-driven future in gaming. The American Gambling Awards, produced by Gambling.com Group Limited (Nasdaq: GAMB) ("Gambling.com G.